rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
8
|
pubmed:dateCreated |
2005-1-26
|
pubmed:abstractText |
Ureteral stents are a significant source of pain and discomfort for many urologic patients. A novel approach to addressing this problem is the intravesical instillation of a selected pharmacologic agent after stent insertion. The purpose of this study was to assess the safety and efficacy of intravesical instillation of various agents in reducing ureteral stent-associated discomfort in patients requiring a stent after extracorporeal shockwave lithotripsy (SWL).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0892-7790
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
18
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
723-30
|
pubmed:meshHeading |
pubmed-meshheading:15659891-Administration, Intravesical,
pubmed-meshheading:15659891-Anesthetics, Local,
pubmed-meshheading:15659891-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:15659891-Double-Blind Method,
pubmed-meshheading:15659891-Female,
pubmed-meshheading:15659891-Humans,
pubmed-meshheading:15659891-Ketorolac Tromethamine,
pubmed-meshheading:15659891-Lidocaine,
pubmed-meshheading:15659891-Lithotripsy,
pubmed-meshheading:15659891-Male,
pubmed-meshheading:15659891-Mandelic Acids,
pubmed-meshheading:15659891-Middle Aged,
pubmed-meshheading:15659891-Pain,
pubmed-meshheading:15659891-Parasympatholytics,
pubmed-meshheading:15659891-Stents,
pubmed-meshheading:15659891-Ureter
|
pubmed:year |
2004
|
pubmed:articleTitle |
Double-blind randomized controlled trial assessing the safety and efficacy of intravesical agents for ureteral stent symptoms after extracorporeal shockwave lithotripsy.
|
pubmed:affiliation |
Division of Urology, University of Western Ontario, London, Ontario, Canada.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|